Cargando…

Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies

BACKGROUND: Clustering of breast and colorectal cancer has been observed within some families and cannot be explained by chance or known high-risk mutations in major susceptibility genes. Potential shared genetic susceptibility between breast and colorectal cancer, not explained by high-penetrance g...

Descripción completa

Detalles Bibliográficos
Autores principales: Pande, Mala, Joon, Aron, Brewster, Abenaa M., Chen, Wei V., Hopper, John L., Eng, Cathy, Shete, Sanjay, Casey, Graham, Schumacher, Fredrick, Lin, Yi, Harrison, Tabitha A., White, Emily, Ahsan, Habibul, Andrulis, Irene L., Whittemore, Alice S., John, Esther M., Ko Win, Aung, Makalic, Enes, Schmidt, Daniel F., Kapuscinski, Miroslaw K., Ochs-Balcom, Heather M., Gallinger, Steven, Jenkins, Mark A., Newcomb, Polly A., Lindor, Noralane M., Peters, Ulrike, Amos, Christopher I., Lynch, Patrick M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919670/
https://www.ncbi.nlm.nih.gov/pubmed/29698419
http://dx.doi.org/10.1371/journal.pone.0196245
Descripción
Sumario:BACKGROUND: Clustering of breast and colorectal cancer has been observed within some families and cannot be explained by chance or known high-risk mutations in major susceptibility genes. Potential shared genetic susceptibility between breast and colorectal cancer, not explained by high-penetrance genes, has been postulated. We hypothesized that yet undiscovered genetic variants predispose to a breast-colorectal cancer phenotype. METHODS: To identify variants associated with a breast-colorectal cancer phenotype, we analyzed genome-wide association study (GWAS) data from cases and controls that met the following criteria: cases (n = 985) were women with breast cancer who had one or more first- or second-degree relatives with colorectal cancer, men/women with colorectal cancer who had one or more first- or second-degree relatives with breast cancer, and women diagnosed with both breast and colorectal cancer. Controls (n = 1769), were unrelated, breast and colorectal cancer-free, and age- and sex- frequency-matched to cases. After imputation, 6,220,060 variants were analyzed using the discovery set and variants associated with the breast-colorectal cancer phenotype at P<5.0E-04 (n = 549, at 60 loci) were analyzed for replication (n = 293 cases and 2,103 controls). RESULTS: Multiple correlated SNPs in intron 1 of the ROBO1 gene were suggestively associated with the breast-colorectal cancer phenotype in the discovery and replication data (most significant; rs7430339, P(discovery) = 1.2E-04; rs7429100, P(replication) = 2.8E-03). In meta-analysis of the discovery and replication data, the most significant association remained at rs7429100 (P = 1.84E-06). CONCLUSION: The results of this exploratory analysis did not find clear evidence for a susceptibility locus with a pleiotropic effect on hereditary breast and colorectal cancer risk, although the suggestive association of genetic variation in the region of ROBO1, a potential tumor suppressor gene, merits further investigation.